TDOC analyst estimates
Teladoc Health (TDOC) analyst ratings, the average price target and its range, and every firm's latest call.
TDOC analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Jul 30, 2026 | Evercore ISI | Teladoc price target lowered to $7.50 from $10 at Evercore ISI | $7.50 |
| Jul 30, 2026 | Jefferies | Teladoc price target lowered to $8 from $9 at Jefferies | $8.00 |
| Jul 21, 2026 | Canaccord Genuity | Teladoc price target raised to $11 from $10 at Canaccord | $11.00 |
| Apr 8, 2026 | Evercore ISI | Teladoc price target raised to $6 from $5 at Evercore ISI | $6.00 |
| Mar 10, 2026 | Deutsche Bank | Deutsche Bank Upgrades Teladoc (TDOC) to Buy | $11.00 |
| Feb 26, 2026 | Wells Fargo | Teladoc (TDOC) PT Lowered to $6 at Wells Fargo | $6.00 |
| Feb 26, 2026 | Stifel Nicolaus | Teladoc (TDOC) PT Lowered to $6 at Stifel Following Q4 Results | $6.00 |
| Jan 16, 2026 | Goldman Sachs | Teladoc price target lowered to $8 from $9 at Goldman Sachs | $8.00 |
| Jan 9, 2026 | Goldman Sachs | Teladoc price target lowered to $9 from $10 at Goldman Sachs | $9.00 |
| Dec 8, 2025 | Barclays | Teladoc initiated with an Equal Weight at Barclays | $8.50 |
| Oct 30, 2025 | Stifel Nicolaus | Stifel Reiterates Hold Rating on Teladoc (TDOC) | $8.00 |
| Jul 30, 2025 | Raymond James | Teladoc price target lowered to $10 from $12 at Cantor Fitzgerald | $10.00 |
| Dec 4, 2024 | Piper Sandler | Teladoc (TDOC) PT Raised to $13 at Piper Sandler | $13.00 |
| Oct 31, 2024 | Citigroup | Teladoc (TDOC) PT Raised to $11 at Citi | $11.00 |
| Oct 30, 2024 | Evercore ISI | Evercore ISI Reiterates In Line Rating on Teladoc (TDOC) | $9.00 |
- 15 firms rate TDOC: 5 buy, 10 hold, 0 sell.
- The average price target is $8.83 from 3 analysts, from $7.50 to $11.00.
Updated 2026-11-02 23:11 UTC